Index of medicine substances

Dabigatran etexilat  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Direct thrombin inhibitors (B01AE07)

Dabrafenib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors (L01EC02)

Dacarbazine  •  Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents (L01AX04)

Daclatasvir  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX14)

Daclizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA08)

Dacomitinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (L01EB07)

Dactynomicin  •  Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Actinomycines (L01DA01)

Dalbavancin  •  Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials (J01XA04)

Dalteparin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group (B01AB04)

Damoctocog alfa pegol  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD02)

Dandelion  •  Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy (A05AXN1)

Danicopan  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors (L04AJ09)

Dantrolen sodium  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, directly acting agents | Dantrolene and derivatives (M03CA01)

Dapagliflozin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sodium-glucose co-transporter 2 (SGLT2) inhibitors (A10BK01)

Dapagliflozin + metformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD15)

Dapoxetine  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Other urologicals (G04BX14)

Dapsone  •  Antiinfectives for systemic use | Drugs for treatment of lepra (J04BA02)

Daptomycin  •  Antiinfectives for systemic use | Other antibacterials (J01XX09)

Daratumumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd38 (clusters of differentiation 38) inhibitors (L01FC01)

Darbepoetin alfa  •  Blood and blood forming organs | Other antianemic preparations (B03XA02)

Darifenacin  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs for urinary frequency and incontinence (G04BD10)

Darolutamide  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens (L02BB06)

Darunavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE10)

Darunavir + cobicistat  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR14)

Darunavir + cobicistat + emtricitabine + tenofovir alafenamide  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR22)

Darvadstrocel  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants (L04AX08)

Dasabuvir  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections (J05AP09)

Dasatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors (L01EA02)

Daunorubicin  •  Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances (L01DB02)

Daunorubicin + cytarabine  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Combinations of antineoplastic agents (L01XY01)